Monday, April 1, 2019

Researchers optimize gene editing for SCD and beta thalassemia

Gene editing of patients' blood stem cells can potentially cure many blood disorders. But introducing targeted edits into these cells has been challenging, and the edits aren't always stable once the cells engraft in the bone marrow. Researchers now report a CRISPR approach that overcomes these technical challenges.

from Top Health News -- ScienceDaily https://ift.tt/2VcPfvS
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists create “smart” DNA drug that targets cancer cells with extreme precision

Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, i...